News

Your oral health is even linked to kidney function. A 2024studysuggests that chronic kidney disease may also be linked with tooth loss. The study found that low tooth count is linked with systemic ...
Oral Suspension, 10mg/mL, approved under New Drug Application (NDA# N218772). The ‘869 patent and the ‘273 patent, both titled, “Losartan Liquid Formulations and Methods of Use,” cover ...
You can save up to 49% on oral care products, from toothbrushes and water flossers to toothpaste and mouthwash. Here are 10 oral care essentials you can't miss during the two-week event ...
A dental expert isn’t holding his tongue about a viral oral hygiene trend that could do more harm than good — and even kill you. “What many don’t understand is that a tongue scraper can ...
Arbli is supplied as an peppermint-flavored oral suspension containing 10mg/mL of losartan potassium in 165mL bottles. The Food and Drug Administration (FDA) has approved Arbli ™, an oral ...
Cefdinir is a generic drug that comes as an oral capsule and oral suspension (a type of liquid mixture). Cefdinir is not available in a brand-name version. Read on to learn about potential common ...
Hikma is introducing mercaptopurine oral suspension, in a 20mg/ml dose, which is the first generic of this product. Hikma was the first approved applicant with a Competitive Generic Therapy ...
According to the agency, stability studies have shown that the reconstituted oral suspension becomes unstable after mixing, leading to a loss of efficacy over time. It said this can result in ...
This means more efficient treatment delivery for patients who need it most, such as patients for our first oral suspension medication application in erectile dysfunction. PE: How was your proprietary ...
This article is a bibliographic review of preparation of extemporaneous oral liquid from solid oral dosage forms ... enalapril, lisinopril, metoprolol, moxifloxacin, propafenone and ribavirin. These ...
Avadel Pharmaceuticals plc-- LUMRYZ is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with ...